About Vectura

We are a specialist inhalation CDMO that provides innovative inhaled drug development solutions to help customers bring their medicines to patients.

Our Science

See how our scientific innovation and expertise can support your inhaled development programme

Find out more

Product development

Tailored inhalation services for you

Track record

Choose a partner to help you succeed

News

Mundipharma and Vectura announce plans to reformulate flutiform®

16/04/2024

FOR MEDICAL AND TRADE MEDIA ONLY Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metered-dose inhaler...

£58m Inhalation Centre of Excellence granted planning permission

27/09/2022

We have been granted planning permission for a new 10,000-square metre facility on Bristol & Bath Science Park in south-west...

Environmental, Social and Governance (ESG) Strategy

Know more about our commitment to creating long-term growth by embedding sustainability in all our business practices.

DOWNLOAD ESG REPORT